QUARTERLY RESULTS Alembic Pharmaceuticals Q4 Results: Net profit jumps 29% YoY to Rs 202.70 crore, revenue up 4% May 15, 2026
Top Stocks For Trade Today, April 27 – Paytm, RBL Bank, IndusInd Bank, L&T Finance, Alembic Pharma and more Apr 27, 2026
Alembic Pharmaceuticals receives USFDA approval for Fingolimod capsules; targets $145 million market Apr 25, 2026
Alembic Pharmaceuticals receives USFDA approval for Fingolimod Capsules with market size of US$ 145 million Apr 25, 2026
Alembic Pharmaceuticals receives USFDA approval for Dapagliflozin tablets with US$ 10.487 billion market size Apr 7, 2026